A phase II trial of gemcitabine and erlotinib followed by ChemoProton therapy plus capecitabine and oxaliplatin for locally advanced pancreatic cancer

Samrat M. Sanghvi, Alex R. Coffman, Chung-Tsen Hsueh, Joseph Kang, Annie Park, Naveenraj L. Solomon, Carlos A. Garberoglio, Mark E. Reeves, Jerry D. Slater, Gary Y. Yang